Significance of Induction Phenomena
A number of foreign compounds induce the proliferation of the hepatic smooth endoplasmatic reticulum and thereby increase the activity of monooxygenases that metabolize drugs and other foreign compound. With reference to the safety of food additives some antioxidants have been examined by various authors for their inducing capacity, in doses well above those ingested with treated food and above the stipulated accepted daily intake (ADI). Thus feeding of rats with the very high dose of 500 mg/kg body weight of butylated hydroxtoluene (BHT) resulted in an increase in its own oxidative metabolism. Also in monkeys BHT produces an inductive increase of microsomal enzyme activity, cytochrome P 450, and a proliferation of smooth endoplasmatic reticulum. The closely related antioxidant butylated hydroxyanisole (BHA) leads to similar effects in mice. Recent studies with ethoxyquin (EQ) have shown that this antioxidant stimulates the formation of a form of cytochrome P 450 which resembles the phenobarbital-inducible type. EQ itself is also an inhibitor of mixed function monooxygenase. The naturally occuring flavouring agents safrole and isosafrole in high doses also induce hepatic mono-oxygenations. Spectroscopic examination has revealed, however, that another type of cytochrome with characteristic binding of a suspected safrole metabolite is produced. This complex shows absorption maxima at 427 and 455nm and can be dissociated by adding a number of different lipophilic agents, including safrole itself. In a time dependent displacement reaction the characteristic spectrum decreases and is replaced by a classical binding spectrum of the displacer itself.
By these examples it can be shown that food additives exert a number of effects on hepatic drug inactivating systems. However, no risk of hepatic changes can be seen from the small amounts of antioxidants ingested in balanced human nutrition.
KeywordsNADPH Styrene Cyclohexane Butylate Biphenyl
Unable to display preview. Download preview PDF.
- Bridges, J.W., Dickins, M., Moloney, S.J., Elcombe, C.R., Netter, K.J.: Biochemical Pharmacology, in press (1977)Google Scholar
- Commission of the European Communities: Ethoxyquin Working Document 1295/VI/ 74-E (1974)Google Scholar
- Lindner, E.: Toxikologie der Nahrungsmittel, p. 53. Stuttgart: Georg Thieme Verlag (1974)Google Scholar
- Long, E.L., Nelson, A.A., Fitzhugh, O.G., Hansen, W.H.: Archives of Pathology 75, 595 (1963)Google Scholar
- Marino, A.A., Mitchell, J.T.: Proceedings of the Society of experimental Biology and Medicine 140, 122 (1972)Google Scholar
- Parke, D.V., Rahman, H.: Biochemical Journal 119, 53 p (1970)Google Scholar
- Parke, D.V.: Biochemical Journal 130, 53 p (1972)Google Scholar
- Schulte Hermann, R., Koransky, W., Leberl, C., Noack, G.: Virchows Archiv, Abt. B, Zellpathologie 9, 125 (1971)Google Scholar
- Stuckey, B.N.: In: (Th. E. Furia, ed.), Handbook of Food Additives 2nd ed. p. 215 Cleveland: CRC Press (1975)Google Scholar
- WHO Food Additives Series No. 5: Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulsifiers and thickening agents, p. 148, World Health Organization, Geneva (1974)Google Scholar
- WHO Technical Report Series No. 599: Evaluation of certain food additives. Annex 2, p. 28, World Health Organization, Geneva (1976)Google Scholar